(Q69567038)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3731566%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

title

Effect of propranolol on indices of intermittent myocardial ischemia, assessed by exercise testing and ambulatory ST-segment monitoring (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3731566%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

1 reference

N S Khurmi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3731566%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

M J Bowles

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3731566%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

M J O'Hara

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3731566%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

E B Raftery

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3731566%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

publication date

1 August 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3731566%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3731566%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3731566%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3731566%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

page(s)

391-397

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3731566%20AND%20SRC:MED&resulttype=core&format=json

Coronary artery syndromes after sudden propranolol withdrawal

3 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Dose response effectiveness of propranolol for the treatment of angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

The medical treatment of angina pectoris II. Design of an antianginal drug study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Effects of Propranolol and Isosorbide Dinitrate on Exercise Performance and Adrenergic Activity in Patients with Angina Pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Efficacy of once daily penbutolol in chronic stable angina. An objective comparison with long-acting propranolol

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Beta-adrenergic blocking agents for the treatment of angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Inotropic changes in the left ventricle: the effect of changes in heart rate, aortic pressure and end-diastolic pressure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Propranolol in patients with angina pectoris.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Medical management of patients with angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Adverse reactions to propranolol in hospitalized medical patients: A report from the Boston Collaborative Drug Surveillance Program

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

The effect of diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized, and placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Improvement of myocardial metabolism in coronary arterial disease by beta-blockade

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Effect of propranolol on myocardial oxygen consumption and its hemodynamic correlates during upright exercise.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Short- and long-term efficacy of nicardipine, assessed by placebo-controlled single- and double-blind crossover trials in patients with chronic stable angina

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Reproducibility of multistage graded exercise testing in patients with chronic stable angina

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Randomized double-blind comparison of gallopamil and propranolol in stable angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Transient transmural reduction of myocardial blood flow demonstrated by thallium-201 scintigraphy, as a cause of variant angina

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Hemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Acute myocardial infarction with normal and near normal coronary arteries. Documentation with coronary arteriography within 12 1/2 hours of the onset of symptoms in two cases (three episodes)

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Comparison of slow-release pindolol, standard pindolol, and propranolol in angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

A Comparative Study of Nitroglycerin and Propranolol

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Relation of Heart Rate and Systolic Blood Pressure to the Onset of Pain in Angina Pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Effects of exercise on myocardial force-velocity relations in intact unanesthetized man: relative roles of changes in heart rate, sympathetic activity, and ventricular dimensions

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Propranolol withdrawal syndrome - why?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Unwanted effects of propranolol.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Cardiac failure with propranolol.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Ambulatory ST segment monitoring. Problems, pitfalls, solutions, and clinical application

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Randomized double-blind comparison of verapamil and nifedipine in chronic stable angina

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Objective evaluation of three dose levels of diltiazem in patients with chronic stable angina

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Comparison of adrenergic beta-receptor antagonists in angina pectoris.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Cardiovascular pharmacology of propranolol in man

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960090807

7 January 2021

Identifiers

DOI

10.1002/CLC.4960090807

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3731566%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

1 reference